(All)

Editorial: Nanobyte
Radhika A. Vaishnav
3(1) Pages 1-1

Review Article: Past, present, and future of molecular oncology in India
Mishti Jain
2(1) Pages 1-3

Editorial: Changing face of genomics in cancer medicine: Which “avatar” to treat?
Radhika A. Vaishnav
1(1) Pages 1-1

Figure
Editorial: Nanobyte - Perspectives and milestones in molecular biology and immuno-oncology
Radhika A. Vaishnav
4(1) Pages 1-2

Review Article: Advances in cancer immunology and cancer immunotherapeutics
Rohit Kumar and Sanjay R. Jain
3(1) Pages 2-11

Review Article: Pharmacogenetics in oncology: Where we stand today?
Padmaj S. Kulkarni
1(1) Pages 2-6

Figure
Conference Review: Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology - A present status
Prashant MehtaVineet Talwar and Ankur Bahl
4(1) Pages 3-5

Review Article: Circulating tumor cells in breast cancer
Akhil Jain, Moushumi Suryavanshi, Ullas BatraPankaj Goyal and Dinesh Doval
2(1) Pages 4-10

Figure
Original Article: Special considerations for consent in immuno-oncology - Medic LAWgic recommendations
Purvish M.Parikh, Karishma Jhaveri, Ankur Bahl, Vineet Talwar, Pritish Gandhi, Randeep SinghSudeep Shreshta and TP Sahoo
4(1) Pages 6-8

Review Article: Genomic assays in breast cancer: Issues yet to settle?
Maheboob M. Basade and Vishwapriya M. Godkhindi
1(1) Pages 7-9

1    2    3    4    5    6